These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Effects of berberine on differentiation and bone resorption of osteoclasts derived from rat bone marrow cells.
    Author: Wei P, Jiao L, Qin LP, Yan F, Han T, Zhang QY.
    Journal: Zhong Xi Yi Jie He Xue Bao; 2009 Apr; 7(4):342-8. PubMed ID: 19361364.
    Abstract:
    OBJECTIVE: To observe the effects of berberine on osteoclastic differentiation and bone resorption action in vitro, and to investigate the cellular mechanism of its inhibitory effects on bone resorption. METHODS: The multinucleated osteoclasts (MNCs) were derived by 1,25-dihydroxyvitamin D3 and dexamethasone from bone marrow cells in the coculture system with primary osteoblastic cells. The tartrate-resistant acid phosphatase (TRAP) staining and image analysis of bone resorption pit on dental slices were used to identify osteoclast. The activity of TRAP was measured by p-nitrophenyl sodium phosphate assay. The bone resorption pit area on the bone slices formed by osteoclasts was measured by computer image processing. RESULTS: At the concentrations of 0.1, 1 and 10 micromol/L, berberine dose-dependently suppressed the formation of TRAP-positive multinucleated cells, the TRAP activity and the osteoclastic bone resorption. The strongest inhibitory effect was exhibited at the concentration of 10 micromol/L, with the inhibiting rate of 60.45%, 42.12% and 72.69% respectively. CONCLUSION: Berberine can decrease bone loss through inhibition of osteoclast formation, differentiation and bone resorption.
    [Abstract] [Full Text] [Related] [New Search]